It is also a potent tumor suppressor that antagonizes PI3K/Akt signaling and the downstream mammalian target of the rapamycin (mTOR) signaling pathway (Miranda-Gonçalves et al., 2018). The gene discussed is AKT1; the disease is neoplasm.